Cargando…

Risk of COVID‐19 infection in adult patients with atopic eczema and psoriasis: a single‐centre cross‐sectional study

Detalles Bibliográficos
Autores principales:	Yiu, Z.Z.N., Harding‐Oredugba, G., Griffiths, C.E.M., Warren, R.B., McMullen, E., Hunter, H.J.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250602/ https://www.ncbi.nlm.nih.gov/pubmed/33730411 http://dx.doi.org/10.1111/bjd.20062

Ejemplares similares

Antibody responses to single‐dose SARS‐CoV‐2 vaccination in patients receiving immunomodulators for immune‐mediated inflammatory disease
por: Al‐Janabi, A., et al.
Publicado: (2021)

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta‐analysis of randomized controlled trials
por: Rungapiromnan, W., et al.
Publicado: (2017)

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real‐world populations in psoriasis
por: Yiu, Z.Z.N., et al.
Publicado: (2019)

Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review
por: Mason, K.J., et al.
Publicado: (2019)

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
por: Yiu, Z.Z.N., et al.
Publicado: (2018)

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021)

Can atopic eczema and psoriasis coexist? A systematic review and meta‐analysis
por: Cunliffe, A., et al.
Publicado: (2021)

Atopic Eczema
por: Wright, Stephen
Publicado: (1991)

Cross-sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis
por: Ahn, Hye-Jin, et al.
Publicado: (2019)

The top 10 research priorities for psoriasis in the U.K.: results of a James Lind Alliance psoriasis Priority Setting Partnership
por: Majeed‐Ariss, R., et al.
Publicado: (2019)

Therapy of atopic eczema
por: Werfel, Thomas, et al.
Publicado: (2006)

Eczema Coxsackium
por: Ganguly, Satyaki, et al.
Publicado: (2016)

Treatment of Eczema
por: Osborn, T. C.
Publicado: (1885)

‘Mind the gap’: what patients and clinicians believe is ‘unknown’ about psoriasis
por: Majeed‐Ariss, R., et al.
Publicado: (2020)

A Pilot Study to Evaluate Dermoscopic Patterns in Eczema at Rural Based Tertiary Care Centre
por: Nair, Pragya A., et al.
Publicado: (2021)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Risk factors for mental illness in adults with atopic eczema or psoriasis: protocol for a systematic review
por: Adesanya, Elizabeth I, et al.
Publicado: (2020)

Partner bereavement and risk of psoriasis and atopic eczema: cohort studies in the U.K. and Denmark
por: Wong, A.Y.S., et al.
Publicado: (2020)

Paradoxical eczema in patients with psoriasis receiving biologics: a case series
por: Al‐Janabi, Ali, et al.
Publicado: (2022)

Nature of Eczema and Psoriasis
Publicado: (1878)

Stomatitis and Scrotal Eczema
por: Ramchandani, K. T.
Publicado: (1918)

Stomatitis and Scrotal Eczema
por: Ghosh, Nisanath
Publicado: (1918)

Probiotics and infantile atopic eczema
por: Akelma, Ahmet Zülfikar, et al.
Publicado: (2015)

Atopic eczema is an environmental disease
por: Luschkova, Daria, et al.
Publicado: (2021)

The sound of silence: where are the voices of patients in eczema guideline development?
por: Capozza, Korey, et al.
Publicado: (2022)

A rapid access clinic for psoriasis: first experiences
por: Reid, Claire, et al.
Publicado: (2022)

USE OF METHOTREXATE IN RECALCITRANT ECZEMA
por: Mittal, Asit, et al.
Publicado: (2011)

Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms
por: Warren, RB, et al.
Publicado: (2009)

Microbiota in Healthy Skin and in Atopic Eczema
por: Baviera, Giuseppe, et al.
Publicado: (2014)

Vitamin D and the Development of Atopic Eczema
por: Palmer, Debra J.
Publicado: (2015)

Multiple Myeloma and Atopic Eczema in an Adult
por: Hossain, Mohammad Amir, et al.
Publicado: (2015)

The Importance of Acidification in Atopic Eczema: An Underexplored Avenue for Treatment
por: Panther, David J., et al.
Publicado: (2015)

Understanding economic evidence for the prevention and treatment of atopic eczema
por: Sach, T.H., et al.
Publicado: (2019)

Towards More Shared Decision Making in Dermatology: Development of Evidence-based Decision Cards for Psoriasis and Atopic Eczema Treatments
por: VERMEULEN, Francisca M., et al.
Publicado: (2020)

Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema
por: Berekméri, Anna, et al.
Publicado: (2018)

Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey
por: Bechman, Katie, et al.
Publicado: (2022)

Research statistics in Atopic Eczema: what disease is this?
por: Hon, Kam-Lun Ellis, et al.
Publicado: (2012)

Pimecrolimus cream in the management of patients with atopic eczema
por: Spergel, Jonathan M
Publicado: (2009)

A Comprehensive Review of the Treatment of Atopic Eczema
por: Lee, Ji Hyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9i7qkc7nr6ulhlbel6dlrucpqe